EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets

Tadeusz W Inglot iD

Journal of Computer-Aided Molecular Design · 2025

DOI: 10.1007/s10822-025-00646-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Computer-Aided Molecular Design, 2025. Verfasst von Tadeusz W Inglot. Beteiligte Einrichtung: Department of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090, Lublin, Poland. tadeusz.inglot@umlub.pl. Hauptthemen laut MEDLINE: ErbB Receptors, Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study combines experimental and computational approaches to investigate the molecular geometry and physicochemical properties of vildagliptin (VILD). Using methods such as UV-Vis, spectrofluorimetry, FTIR/Raman, and circular dichroism alongside DFT, molecular docking, and dynamics simulations, a reliable molecular model was obtained that aligns closely with X-ray crystallographic data. This model enabled accurate predictions of vibrational frequencies and systematic assignments of vibrational modes. Analyses, including Hirshfeld surface mapping, molecular electrostatic potential, HOMO-LUMO energetics, Fukui indices, and natural population analysis, provided clear insights into VILD's reactivity, while NBO and TD-DFT studies elucidated key stabilizing interactions and high-energy electronic transitions. NTO visualization further clarified orbital dynamics, and circular dichroism measurements explained the molecular basis of the Cotton effect. Additionally, molecular docking and molecular dynamics simulations confirmed the formation of stable complexes with EGFR, VEGFR2, and HER2 receptor proteins, suggesting potential anticancer activity. The main purpose of this publication is to fill existing gaps in our understanding of VILD's molecular behavior and offer a robust foundation for rational drug design and improved therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsVascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsErb-b2 Receptor Tyrosine KinasesVildagliptinMolecular Docking SimulationHumansMolecular Dynamics SimulationDensity Functional Theory

Stichwörter der Autor:innen

DFTFTIRRamanSpectroscopyVildagliptin

Substanzen

ErbB ReceptorsVascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsErb-b2 Receptor Tyrosine KinasesVildagliptinEGFR protein, humanERBB2 protein, humanKDR protein, human

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090, Lublin, Poland. tadeusz.inglot@umlub.pl.

ORCID-Profile: Tadeusz W Inglot

Zitieren

APA

Inglot, T. W. (2025). Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets. Journal of Computer-Aided Molecular Design. https://doi.org/10.1007/s10822-025-00646-9

Vancouver

Inglot TW. Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets. Journal of Computer-Aided Molecular Design. 2025. doi:10.1007/s10822-025-00646-9

BibTeX
@article{Inglot2025,
  author = {Inglot, Tadeusz W},
  title = {Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets},
  journal = {Journal of Computer-Aided Molecular Design},
  year = {2025},
  doi = {10.1007/s10822-025-00646-9}
}
Kostenlos starten →